Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. [electronic resource]
Producer: 20050808Description: 960-5 p. digitalISSN:- 0017-5749
- Administration, Oral
- Administration, Rectal
- Adolescent
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- administration & dosage
- Colitis, Ulcerative -- complications
- Double-Blind Method
- Enema
- Female
- Gastrointestinal Hemorrhage -- drug therapy
- Humans
- Male
- Mesalamine -- administration & dosage
- Middle Aged
- Patient Acceptance of Health Care
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.